Literature DB >> 20662692

Contrast-induced nephropathy after a second contrast exposure.

Hariprasad Trivedi1, W Dennis Foley.   

Abstract

BACKGROUND: The risk of contrast-induced nephropathy (CIN) after repeated contrast exposure has not been evaluated.
METHODS: We prospectively evaluated the effects of two contrast exposures during an investigational study of a new computerized tomography (CT) scanner. Adult subjects who underwent a variety of contrast-enhanced imaging procedures with conventional apparatus, as part of routine care, were invited to undergo a second contrast-enhanced research scan. Subjects were required to have an estimated glomerular filtration rate (eGFR) >60 mL/min/1.73 m(2) and a serum creatinine (sCr) value measured immediately prior to the second contrast exposure that was <125% of that measured prior to the first imaging study.
RESULTS: Twenty-eight subjects underwent a second contrast exposure after a mean interval of 20 +/- 13 days (75% males, 89% Caucasians, 21% diabetics, mean age 60.6 +/- 6 years, mean contrast volume 130 +/- 42 mL). There was a significant increase in mean sCr and decline in eGFR after the second contrast exposure (sCr 0.93 +/- 0.14 vs. 0.86 +/- 0.15 mg/dL prior, p = 0.027; eGFR 83.9 +/- 13.5 vs. 89.8 +/- 13 mL/min/1.73 m(2) prior, p = 0.028). Four subjects (14.3% of the population) developed CIN.
CONCLUSION: Even in subjects with relatively preserved renal function there is a notable risk of CIN after repeated contrast exposure. This conclusion was unaltered by several sensitivity analyses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20662692     DOI: 10.3109/0886022X.2010.495441

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  16 in total

1.  Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group.

Authors:  Iwao Ohno; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Naoki Kashihara; Hirokazu Okada; Yasuhiro Komatsu; Shozo Tamura; Kazuo Awai; Yasuyuki Yamashita; Ryohei Kuwatsuru; Atsushi Hirayama; Yoshihiko Saito; Toyoaki Murohara; Nagara Tamaki; Akira Sato; Tadateru Takayama; Enyu Imai; Yoshinari Yasuda; Daisuke Koya; Yoshiharu Tsubakihara; Shigeo Horie; Yukunori Korogi; Yoshifumi Narumi; Katsumi Hayakawa; Hiroyuki Daida; Koichi Node; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2013-08       Impact factor: 2.801

2.  Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group.

Authors:  Iwao Ohno; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Naoki Kashihara; Hirokazu Okada; Yasuhiro Komatsu; Shozo Tamura; Kazuo Awai; Yasuyuki Yamashita; Ryohei Kuwatsuru; Atsushi Hirayama; Yoshihiko Saito; Toyoaki Murohara; Nagara Tamaki; Akira Sato; Tadateru Takayama; Enyu Imai; Yoshinari Yasuda; Daisuke Koya; Yoshiharu Tsubakihara; Shigeo Horie; Yukunori Korogi; Yoshifumi Narumi; Katsumi Hayakawa; Hiroyuki Daida; Koichi Node; Isao Kubota
Journal:  Jpn J Radiol       Date:  2013-08       Impact factor: 2.374

3.  Clinical observation of adverse drug reactions to non-ionic iodinated contrast media in population with underlying diseases and risk factors.

Authors:  Xue Li; Heng Liu; Li Zhao; Junling Liu; Li Cai; Lei Liu; Weiguo Zhang
Journal:  Br J Radiol       Date:  2016-12-08       Impact factor: 3.039

4.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

Review 5.  Renal imaging in patients with renal impairment.

Authors:  Jason A Poff; Elizabeth M Hecht; Parvati Ramchandani
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

6.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Jpn J Radiol       Date:  2020-01       Impact factor: 2.374

7.  Canadian Association of Radiologists Guidance on Contrast-Associated Acute Kidney Injury.

Authors:  D Blair Macdonald; Casey D Hurrell; Andreu F Costa; Matthew D F McInnes; Martin O'Malley; Brendan J Barrett; Pierre Antoine Brown; Edward G Clark; Anastasia Hadjivassiliou; Iain Donald Craik Kirkpatrick; Jeremy Rempel; Paul Jeon; Swapnil Hiremath
Journal:  Can J Kidney Health Dis       Date:  2022-05-24

8.  Optimizing contrast medium injection protocol individually with body weight for high-pitch prospective ECG-triggering coronary CT angiography.

Authors:  Jie Liu; Jianbo Gao; Runze Wu; Yonggao Zhang; Lili Hu; Ping Hou
Journal:  Int J Cardiovasc Imaging       Date:  2013-01-04       Impact factor: 2.357

9.  Pulmonary 64-MDCT angiography with 50 mL of iodinated contrast material in an unselected patient population: a feasible protocol.

Authors:  Henrique Simão Trad; Gustavo Santos Boasquevisque; Tiago Rangon Giacometti; Catherine Yang Trad; Orlando Salomão Zoghbi Neto; Clovis Simão Trad
Journal:  Radiol Bras       Date:  2016 Mar-Apr

Review 10.  Contrast-Induced Nephropathy: A Review of Mechanisms and Risks.

Authors:  Elham Shams; Harvey N Mayrovitz
Journal:  Cureus       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.